“allogene-therapeutics” Archives

in
Entry Author Date Location
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
San Francisco Biotech: The Next Generation—Photos and Takeaways 12/26/18 San Francisco
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
Last Chance to Save on Tickets for Xconomy’s Bay Area Biotech Event 11/28/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Allogene, Cortexyme & RDMD Headline Xconomy’s Dec. 5 Biotech Forum 11/08/18 San Francisco
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Allogene’s IPO Raises $288M for Tests of “Off-the-Shelf” Cell Therapy 10/11/18 San Francisco
Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M 10/10/18 San Francisco
Super Saver Rate for San Francisco Biotech Event Ends Tomorrow 10/03/18 National
Allogene Files for IPO to Fund Cancer Cell Therapy Clinical Trials 09/14/18 San Francisco
Xconomy’s San Francisco Event to Showcase Biotech’s Next Generation 09/13/18 San Francisco
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
Page 1 of 1